Firstly, the faster recovery from neutropenia and reduced time for platelet transfusion dependency observed in the MPB-GT group (Fig. 2) is in line with HSCT results, and it importantly suggests that the in vitro manipulation per se does not introduce changes in the overall characteristics of CD34+ cells. The gene discussed is CD34; the disease is neutropenia.